103577-61-3Relevant articles and documents
Safety evaluation of an unexpected incident with a nitro compound
Barbas, Rafael,Botija, Manuel,Camps, Helena,Portell, Anna,Prohens, Rafel,Puigjaner, Cristina
, p. 1131 - 1134 (2007)
An unexpected highly exothermic reaction followed by explosion has been studied by means of reaction calorimetry and adiabatic calorimetry. The investigation of the process shows that the incident took place by a local adiabatic temperature rise in the reactor vessel due to the presence of potassium carbonate, which activated the decomposition of a nitro compound with an unusual low temperature onset The study is completed with an unproved and safer procedure consisting of changing the order of chemicals addition as an alternative approach.
Design and synthesis of N-Aryl isothioureas as a novel class of gastric H+/K+-ATPase inhibitors
Ma, Chao,Wu, Anhui,Wu, Yongqi,Ren, Xuhong,Cheng, Maosheng
, p. 891 - 900 (2014/01/06)
To find new H+/K+-ATPase inhibitors for the treatment of peptic ulcer disease, a series of novel N-aryl isothiourea derivatives were synthesized and their structures were identified by 1H NMR and GC-MS. The effects of these compounds on inhibiting gastric acid secretion were evaluated by the guinea pig stomach mucous membrane study with pantoprazole magnesium as a positive control. The results showed that, of the 37 N-aryl isothiourea compounds synthesized, 20 compounds have comparable or stronger gastric acid inhibitory activities than that of pantoprazole magnesium. The quantitative structure-activity relationships (QSARs) of the N-aryl isothiourea compounds were also studied by comparative molecular field analysis (CoMFA) computation, and the model structure that was supposed to give more powerful bioactivities was finally predicted. A series of novel N-aryl isothiourea derivatives were synthesized and evaluated for their effects of inhibiting gastric acid secretion using the guinea pig stomach mucous membrane study with pantoprazole magnesium as a positive control. Compounds 2c, 2e, and 2k have higher bioactivity. The quantitative structure-activity relationships also defined these structural requirements.
Crystals of benzimidazole derivatives and their production
-
, (2008/06/13)
A substantially solvent-free and stable crystal of the compound of the formula: STR1 wherein the ring A may optionally be substituted, R1 represents hydrogen or an N-protecting group, each of R2, R3 and R4 (1) a hydrogen atom, (2) an alkyl group which may optionally be substituted with halogen atom(s) or (3) an alkoxy group which may optionally be substituted with halogen atom(s) or alkoxy; or its salt, is produced by subjecting a solvate of the compound (I) or its salt to de-solvent treatment, in an industrially advantageous method.